The FDA has escalated enforcement against compounded GLP-1 marketing since September 2025, Novo Nordisk launched the first FDA-approved oral semaglutide pill in January 2026, and compounding pharmacy supply chains are narrowing as regulatory pressure increases
Ejarque M, Guerrero-Prez F, De la morena N, et al
If you notice any adverse effects, consult with your healthcare provider to adjust your regimen accordingly
Why is it choosing to do so now for people living with obesity a recognized, chronic medical condition that, like any other, requires appropriate treatment
Topical side effects: - Mild scalp redness or irritation (5 to 10% of users), typically resolves within days - Temporary shedding increase during the first 2 weeks (adjustment phase) - Contact dermatitis in rare cases, usually from other ingredients in the serum formulation Injectable side effects: - Injection site redness or swelling (resolves within hours) - Mild headache in the first week of use (uncommon) - See the GHK-Cu injection dosage guide for full safety data The copper uglies explained: This is the most important side effect to understand